<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37125923</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Enterovirus D68 VP3 Targets the Interferon Regulatory Factor 7 To Inhibit Type I Interferon Response.</ArticleTitle><Pagination><StartPage>e0413822</StartPage><MedlinePgn>e0413822</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e04138-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.04138-22</ELocationID><Abstract><AbstractText>Enterovirus D68 (EV-D68) is a globally emerging pathogen causing severe respiratory illnesses mainly in children. The protease from EV-D68 could impair type I interferon (IFN-I) production. However, the role of the EV-D68 structural protein in antagonizing host antiviral responses remains largely unknown. We showed that the EV-D68 structural protein VP3 interacted with IFN regulatory factor 7 (IRF7), and this interaction suppressed the phosphorylation and nuclear translocation of IRF7 and then repressed the transcription of IFN. Furthermore, VP3 inhibited the TNF receptor associated factor 6 (TRAF6)-induced ubiquitination of IRF7 by competitive interaction with IRF7. IRF7<sub>Δ305-503</sub> showed much weaker interaction ability to VP3, and VP3<sub>Δ41-50</sub> performed weaker interaction ability with IRF7. The VP3 from enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16) was also found to interact with the IRF7 protein. These results indicate that the enterovirus structural protein VP3 plays a pivotal role in subverting host innate immune responses and may be a potential target for antiviral drug research. <b>IMPORTANCE</b> EV-D68 is a globally emerging pathogen that causes severe respiratory illnesses. Here, we report that EV-D68 inhibits innate immune responses by targeting IRF7. Further investigations revealed that the structural protein VP3 inhibited the TRAF6-induced ubiquitination of IRF7 by competitive interaction with IRF7. These results indicate that the control of IRF7 by VP3 may be a mechanism by which EV-D68 represses IFN-I production.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Mengqian</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5738-2674</Identifier><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Jinyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Keke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sihua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhenwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Tao</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1490-7407</Identifier><AffiliationInfo><Affiliation>School of Life Sciences, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiyun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Environmental Science and Engineering, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050839">Interferon Regulatory Factor-7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048029">TNF Receptor-Associated Factor 6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050839" MajorTopicYN="N">Interferon Regulatory Factor-7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048029" MajorTopicYN="N">TNF Receptor-Associated Factor 6</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">IFN-I</Keyword><Keyword MajorTopicYN="N">Toll-like receptor</Keyword><Keyword MajorTopicYN="N">VP3</Keyword><Keyword MajorTopicYN="N">interferon regulatory factor 7</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>10</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37125923</ArticleId><ArticleId IdType="pmc">PMC10269600</ArticleId><ArticleId IdType="doi">10.1128/spectrum.04138-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xiang Z, Wang J. 2016. Enterovirus D68 and human respiratory infections. Semin Respir Crit Care Med 37:578–585. doi:10.1055/s-0036-1584795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0036-1584795</ArticleId><ArticleId IdType="pmc">PMC7171721</ArticleId><ArticleId IdType="pubmed">27486738</ArticleId></ArticleIdList></Reference><Reference><Citation>Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi:10.1093/oxfordjournals.aje.a120693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Opanda SM, Wamunyokoli F, Khamadi S, Coldren R, Bulimo WD. 2014. Genetic diversity of human enterovirus 68 strains isolated in Kenya using the hypervariable 3'-end of VP1 gene. PLoS One 9:e102866. doi:10.1371/journal.pone.0102866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102866</ArticleId><ArticleId IdType="pmc">PMC4108357</ArticleId><ArticleId IdType="pubmed">25054861</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J, Gao S, Zhu C, Liu S, Li J, Kang J, Wang Z, Wang T. 2020. Typical stress granule proteins interact with the 3' untranslated region of enterovirus D68 to inhibit viral replication. J Virol 94:e02041-19. doi:10.1128/JVI.02041-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02041-19</ArticleId><ArticleId IdType="pmc">PMC7081905</ArticleId><ArticleId IdType="pubmed">31941779</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokarz R, Firth C, Madhi SA, Howie SRC, Wu W, Sall AA, Haq S, Briese T, Lipkin WI. 2012. Worldwide emergence of multiple clades of enterovirus 68. J Gen Virol 93:1952–1958. doi:10.1099/vir.0.043935-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043935-0</ArticleId><ArticleId IdType="pmc">PMC3542132</ArticleId><ArticleId IdType="pubmed">22694903</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, Hassan F, Hoferka S, Jackson MA, Johnson D, Leshem E, Miller L, Nichols JB, Nyquist AC, Obringer E, Patel A, Patel M, Rha B, Schneider E, Schuster JE, Selvarangan R, Seward JF, Turabelidze G, Oberste MS, Pallansch MA, Gerber SI, EV-D68 Working Group . 2015. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 3:879–887. doi:10.1016/S2213-2600(15)00335-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Sanz R, Taravillo I, Reina J, Navascués A, Moreno-Docón A, Aranzamendi M, Romero MP, Del Cuerpo M, Pérez-González C, Pérez-Castro S, Otero A, Cabrerizo M. 2019. Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect 8:1438–1444. doi:10.1080/22221751.2019.1668243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1668243</ArticleId><ArticleId IdType="pmc">PMC6781473</ArticleId><ArticleId IdType="pubmed">31571527</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter C, Niesters HGM, Tyler KL, Abzug MJ, Dominguez SR. 2018. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis 18:e239–e247. doi:10.1016/S1473-3099(18)30094-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19–28. doi:10.1016/j.immuni.2005.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2005.04.010</ArticleId><ArticleId IdType="pubmed">16039576</ArticleId></ArticleIdList></Reference><Reference><Citation>Devasthanam AS. 2014. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence 5:270–277. doi:10.4161/viru.27902.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27902</ArticleId><ArticleId IdType="pmc">PMC3956502</ArticleId><ArticleId IdType="pubmed">24504013</ArticleId></ArticleIdList></Reference><Reference><Citation>Goubau D, Deddouche S, Reis e Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855–869. doi:10.1016/j.immuni.2013.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.05.007</ArticleId><ArticleId IdType="pmc">PMC7111113</ArticleId><ArticleId IdType="pubmed">23706667</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell AM, Gale M, Jr. 2015. RIG-I in RNA virus recognition. Virology 479–480:110–121. doi:10.1016/j.virol.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.017</ArticleId><ArticleId IdType="pmc">PMC4424084</ArticleId><ArticleId IdType="pubmed">25749629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann G. 2017. Nucleic acid immunity. Adv Immunol 133:121–169. doi:10.1016/bs.ai.2016.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ai.2016.11.001</ArticleId><ArticleId IdType="pmc">PMC7112058</ArticleId><ArticleId IdType="pubmed">28215278</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 101:17264–17269. doi:10.1073/pnas.0407639101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0407639101</ArticleId><ArticleId IdType="pmc">PMC535396</ArticleId><ArticleId IdType="pubmed">15563593</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5:730–737. doi:10.1038/ni1087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1087</ArticleId><ArticleId IdType="pubmed">15208624</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, Diamond MS, Colonna M. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459–8464. doi:10.1073/pnas.0603082103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603082103</ArticleId><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105. doi:10.1038/nature04734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172. doi:10.1038/nature04193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04193</ArticleId><ArticleId IdType="pubmed">16177806</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar H, Kawai T, Kato H, Sato S, Takahashi K, Coban C, Yamamoto M, Uematsu S, Ishii KJ, Takeuchi O, Akira S. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J Exp Med 203:1795–1803. doi:10.1084/jem.20060792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20060792</ArticleId><ArticleId IdType="pmc">PMC2118350</ArticleId><ArticleId IdType="pubmed">16785313</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J. 2009. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 4:e5674. doi:10.1371/journal.pone.0005674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005674</ArticleId><ArticleId IdType="pmc">PMC2682567</ArticleId><ArticleId IdType="pubmed">19479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682. doi:10.1016/j.cell.2005.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740. doi:10.1016/j.molcel.2005.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2005.08.014</ArticleId><ArticleId IdType="pubmed">16153868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning S, Campos AD, Darnay BG, Bentz GL, Pagano JS. 2008. TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol Cell Biol 28:6536–6546. doi:10.1128/MCB.00785-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00785-08</ArticleId><ArticleId IdType="pmc">PMC2577435</ArticleId><ArticleId IdType="pubmed">18710948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Pang Z, Zhou Z, Li X, Liu S, Cheng J, Liu P, Tan W, Wang Z, Wang T. 2021. Enterovirus D68 protease 2A(pro) targets TRAF3 to subvert host innate immune responses. J Virol 95:e01856-20. doi:10.1128/JVI.01856-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01856-20</ArticleId><ArticleId IdType="pmc">PMC7925118</ArticleId><ArticleId IdType="pubmed">33148796</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Lei X, Zhou H, Zhou Z, He B, Wang J. 2014. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J Virol 88:6650–6659. doi:10.1128/JVI.03138-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03138-13</ArticleId><ArticleId IdType="pmc">PMC4054379</ArticleId><ArticleId IdType="pubmed">24672048</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 2016. 3C protease of enterovirus D68 inhibits cellular defense mediated by interferon regulatory factor 7. J Virol 90:1613–1621. doi:10.1128/JVI.02395-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02395-15</ArticleId><ArticleId IdType="pmc">PMC4719596</ArticleId><ArticleId IdType="pubmed">26608321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Su J, Wang H, Chang J, Wang S, Zheng W, Cai Y, Wei W, Gordy JT, Markham R, Kong W, Zhang W, Yu XF. 2017. Disruption of MDA5-mediated innate immune responses by the 3C proteins of coxsackievirus A16, coxsackievirus A6, and enterovirus D68. J Virol 91:e00546-17. doi:10.1128/JVI.00546-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00546-17</ArticleId><ArticleId IdType="pmc">PMC5469270</ArticleId><ArticleId IdType="pubmed">28424289</ArticleId></ArticleIdList></Reference><Reference><Citation>Falah N, Montserret R, Lelogeais V, Schuffenecker I, Lina B, Cortay JC, Violot S. 2012. Blocking human enterovirus 71 replication by targeting viral 2A protease. J Antimicrob Chemother 67:2865–2869. doi:10.1093/jac/dks304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dks304</ArticleId><ArticleId IdType="pubmed">22865380</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz JL, Baltimore D. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694–6704. doi:10.1093/emboj/18.23.6694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.23.6694</ArticleId><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chariot A, Leonardi A, Muller J, Bonif M, Brown K, Siebenlist U. 2002. Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J Biol Chem 277:37029–37036. doi:10.1074/jbc.M205069200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M205069200</ArticleId><ArticleId IdType="pubmed">12133833</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20:17–22. doi:10.1016/j.coi.2008.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2008.01.002</ArticleId><ArticleId IdType="pubmed">18272355</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Tao H, He J, Huang SY. 2020. The HDOCK server for integrated protein-protein docking. Nat Protoc 15:1829–1852. doi:10.1038/s41596-020-0312-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-020-0312-x</ArticleId><ArticleId IdType="pubmed">32269383</ArticleId></ArticleIdList></Reference><Reference><Citation>Tunyasuvunakool K, Adler J, Wu Z, Green T, Zielinski M, Žídek A, Bridgland A, Cowie A, Meyer C, Laydon A, Velankar S, Kleywegt GJ, Bateman A, Evans R, Pritzel A, Figurnov M, Ronneberger O, Bates R, Kohl SAA, Potapenko A, Ballard AJ, Romera-Paredes B, Nikolov S, Jain R, Clancy E, Reiman D, Petersen S, Senior AW, Kavukcuoglu K, Birney E, Kohli P, Jumper J, Hassabis D. 2021. Highly accurate protein structure prediction for the human proteome. Nature 596:590–596. doi:10.1038/s41586-021-03828-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03828-1</ArticleId><ArticleId IdType="pmc">PMC8387240</ArticleId><ArticleId IdType="pubmed">34293799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36:166–174. doi:10.1016/j.immuni.2012.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.01.011</ArticleId><ArticleId IdType="pmc">PMC3294371</ArticleId><ArticleId IdType="pubmed">22365663</ArticleId></ArticleIdList></Reference><Reference><Citation>de Breyne S, Bonderoff JM, Chumakov KM, Lloyd RE, Hellen CU. 2008. Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases. Virology 378:118–122. doi:10.1016/j.virol.2008.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.05.019</ArticleId><ArticleId IdType="pmc">PMC2580754</ArticleId><ArticleId IdType="pubmed">18572216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. doi:10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Hilgenfeld R. 2017. RNA-virus proteases counteracting host innate immunity. FEBS Lett 591:3190–3210. doi:10.1002/1873-3468.12827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12827</ArticleId><ArticleId IdType="pmc">PMC7163997</ArticleId><ArticleId IdType="pubmed">28850669</ArticleId></ArticleIdList></Reference><Reference><Citation>Musharrafieh R, Ma C, Zhang J, Hu Y, Diesing JM, Marty MT, Wang J. 2019. Validating enterovirus D68-2A(pro) as an antiviral drug target and the discovery of telaprevir as a potent D68-2A(pro) inhibitor. J Virol 93:e02221-18. doi:10.1128/JVI.02221-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02221-18</ArticleId><ArticleId IdType="pmc">PMC6430540</ArticleId><ArticleId IdType="pubmed">30674624</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Lei C, Xu Z, Yang F, Liu H, Zhu Z, Li S, Liu X, Shu H, Zheng H. 2016. Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-β signaling pathway. Sci Rep 6:21888. doi:10.1038/srep21888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21888</ArticleId><ArticleId IdType="pmc">PMC4756384</ArticleId><ArticleId IdType="pubmed">26883855</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Yang W, Yang F, Liu H, Zhu Z, Lian K, Lei C, Li S, Liu X, Zheng H, Shu H. 2016. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-β signaling pathway. FASEB J 30:1757–1766. doi:10.1096/fj.15-281410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.15-281410</ArticleId><ArticleId IdType="pubmed">26813975</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 19:623–655. doi:10.1146/annurev.immunol.19.1.623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.19.1.623</ArticleId><ArticleId IdType="pubmed">11244049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496. doi:10.1038/ni921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni921</ArticleId><ArticleId IdType="pubmed">12692549</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T. 2004. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 101:15416–15421. doi:10.1073/pnas.0406933101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0406933101</ArticleId><ArticleId IdType="pmc">PMC523464</ArticleId><ArticleId IdType="pubmed">15492225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikushima H, Negishi H, Taniguchi T. 2013. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harbor Symp Quant Biol 78:105–116. doi:10.1101/sqb.2013.78.020321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2013.78.020321</ArticleId><ArticleId IdType="pubmed">24092468</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Yang B, Hu Y, Zheng Y, Zhou H, Wang Y, Ma Y, Mao K, Yang L, Lin G, Ji Y, Wu X, Sun B. 2013. Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7. J Immunol 191:3393–3399. doi:10.4049/jimmunol.1300740.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300740</ArticleId><ArticleId IdType="pubmed">23956435</ArticleId></ArticleIdList></Reference><Reference><Citation>Welchman RL, Gordon C, Mayer RJ. 2005. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 6:599–609. doi:10.1038/nrm1700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm1700</ArticleId><ArticleId IdType="pubmed">16064136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay D, Riezman H. 2007. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315:201–205. doi:10.1126/science.1127085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1127085</ArticleId><ArticleId IdType="pubmed">17218518</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgs R, Jefferies CA. 2008. Targeting IRFs by ubiquitination: regulating antiviral responses. Biochem Soc Trans 36:453–458. doi:10.1042/BST0360453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0360453</ArticleId><ArticleId IdType="pubmed">18481980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ZJ, Sun LJ. 2009. Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33:275–286. doi:10.1016/j.molcel.2009.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.01.014</ArticleId><ArticleId IdType="pubmed">19217402</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W, Huang S, Zhu H, Zhang B, Wu X. 2020. Interaction between PHB2 and enterovirus A71 VP1 induces autophagy and affects EV-A71 infection. Viruses 12:414. doi:10.3390/v12040414.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12040414</ArticleId><ArticleId IdType="pmc">PMC7232526</ArticleId><ArticleId IdType="pubmed">32276428</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Yang F, Zhu Z, Yang Y, Wang Z, Cao W, Dang W, Li L, Mao R, Liu Y, Tian H, Zhang K, Liu X, Ma J, Zheng H. 2019. Cellular DNAJA3, a novel VP1-interacting protein, inhibits foot-and-mouth disease virus replication by inducing lysosomal degradation of VP1 and attenuating its antagonistic role in the beta interferon signaling pathway. J Virol 93:e00588-19. doi:10.1128/JVI.00588-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00588-19</ArticleId><ArticleId IdType="pmc">PMC6580959</ArticleId><ArticleId IdType="pubmed">30996089</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Z, Wang H, Zhao Z, Chen X, Huan C, Zhang W. 2022. Chemokine PF4 inhibits EV71 and CA16 infections at the entry stage. J Virol 96:e00435-22. doi:10.1128/jvi.00435-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00435-22</ArticleId><ArticleId IdType="pmc">PMC9175630</ArticleId><ArticleId IdType="pubmed">35579435</ArticleId></ArticleIdList></Reference><Reference><Citation>Deater M, Tamhankar M, Lloyd RE. 2022. TDRD3 is an antiviral restriction factor that promotes IFN signaling with G3BP1. PLoS Pathog 18:e1010249. doi:10.1371/journal.ppat.1010249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010249</ArticleId><ArticleId IdType="pmc">PMC8824378</ArticleId><ArticleId IdType="pubmed">35085371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>